Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1241

β-lactoglobulin produced by Aspergillus oryzae

Intended Use: Intended for use as a source of protein at levels ranging from 5 to 35% in meal replacements and supplements, powdered nutritional beverages, nutritional bars, electrolyte-type sports drinks, high protein performance nutritional beverages, milk, milk drinks and drink mixes, milk substitutes, cream and cream substitutes, half & half, cream cheese, cheese spread, whipped cream, yogurt and fermented milk products, spreads, dips, frozen dairy desserts and mixes, cheese used as an ingredient, semi-hard cheese, desserts and mousses, confections, coatings and fillings, cookies, brownies, crackers, popcorn, potato chips, tortilla chips, hard pretzels/snack mix, doughnuts, toaster patties, muffins, French toast, crepes, pancakes, bagels, scones, biscuits, croissants, breads and rolls, English muffins, pizza crust, salad dressings, minor entrée sauces, and egg substitutes.
Basis: Scientific procedures
Notifier: Bon Vivant SAS
Notifier Address: 25 Rue St Jean de Dieu, Batiment C
Lyon, 69007
FRANCE
GRAS Notice (releasable information): GRN 1241 (in PDF) (2.4 MB)
FDA's Letter: Pending
-
-